Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
Holding ORMP?
Track your performance easily
ORMP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.00 - $3.67
Previous CloseN/A
Volume63.61K
Average Volume (3M)174.81K
Market Cap
$93.52M
Enterprise Value-$23.59M
Total Cash (Recent Filing)$6.83M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)20.9
Beta1.28
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.11
Shares Outstanding40,312,070
10 Day Avg. Volume102,567
30 Day Avg. Volume174,815
Standard Deviation0.28
R-Squared0.10
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)69.79
Price to Cash Flow (P/CF)-3.30
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.25
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-17.60
Enterprise Value/Ebitda-2.50
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oramed Pharm News
PremiumCompany Announcements
Oramed Pharmaceuticals Reinforces Scilex Financial Ties
PremiumCompany Announcements
Oramed Pharm Names Avraham Gabay as New CFO
PremiumCompany Announcements
Oramed Pharmaceuticals Seeks New CFO After ResignationOwnership Overview
11.21% Insiders
0.16% Mutual Funds
11.53% Other Institutional Investors
76.00% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ORMP FAQ
What was Oramed Pharmaceuticals’s price range in the past 12 months?
Oramed Pharmaceuticals lowest stock price was $2.00 and its highest was $3.67 in the past 12 months.
What is Oramed Pharmaceuticals’s market cap?
Oramed Pharmaceuticals’s market cap is $93.52M.
When is Oramed Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Oramed Pharmaceuticals’s earnings last quarter?
Oramed Pharmaceuticals released its earnings results on Jan 11, 2024. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.12 by $0.04.
Is Oramed Pharmaceuticals overvalued?
According to Wall Street analysts Oramed Pharmaceuticals’s price is currently Overvalued.
Does Oramed Pharmaceuticals pay dividends?
Oramed Pharmaceuticals does not currently pay dividends.
What is Oramed Pharmaceuticals’s EPS estimate?
Oramed Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oramed Pharmaceuticals have?
Oramed Pharmaceuticals has 40,312,070 shares outstanding.
What happened to Oramed Pharmaceuticals’s price movement after its last earnings report?
Oramed Pharmaceuticals reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.12. Following the earnings report the stock price went down -0.4%.
Which hedge fund is a major shareholder of Oramed Pharmaceuticals?
Currently, no hedge funds are holding shares in ORMP
---
Oramed Pharm Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.58%
12-Months-Change
Fundamentals
Return on Equity
2.92%
Trailing 12-Months
Asset Growth
-28.50%
Trailing 12-Months
Company Description
Oramed Pharmaceuticals
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.
---
Technical Analysis
TG Therapeutics
―
ESSA Pharma
―
Eloxx Pharmaceuticals
―
Moleculin Biotech
―
Alnylam Pharma
―
Agenus
―
---